Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ann Harty
Corrigendum: Pharmacoeconomic Comparison of Aripiprazole Once-Monthly and Paliperidone Palmitate From a Head-To-Head Clinical Trial in Schizophrenia: A US Analysis
Drugs in Context
Molecular Medicine
Pharmacology
Related publications
Real-World Analysis of Switching Patients With Schizophrenia From Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate
Drugs - Real World Outcomes
Pharmacology
Relationship Between Response to Aripiprazole Once-Monthly and Paliperidone Palmitate on Work Readiness and Functioning in Schizophrenia: A Post-Hoc Analysis of the QUALIFY Study
PLoS ONE
Multidisciplinary
Aripiprazole Lauroxil Compared With Paliperidone Palmitate in Patients With Schizophrenia: An Indirect Treatment Comparison
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Head-To-Head Comparison of Aripiprazole and Risperidone for Safety and Treating Autistic Disorders, a Randomized Double Blind Clinical Trial
Child Psychiatry and Human Development
Developmental
Mental Health
Child Health
Educational Psychology
Perinatology
Psychiatry
Pediatrics
Medical Cost-Offset of Once-Monthly Paliperidone Palmitate Monotherapy and Adjunctive Therapy in 15-Month Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Switching From Oral Atypical Antipsychotic Monotherapy to Paliperidone Palmitate Once-Monthly in Non-Acute Patients With Schizophrenia: A Prospective, Open-Label, Interventional Study
Psychopharmacology
Pharmacology
Budget Impact Analysis of Paliperidone Palmitate 3-Monthly for the Treatment of Schizophrenia in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Correction To: Effectiveness of Aripiprazole Once-Monthly in Schizophrenia Patients Pretreated With Oral Aripiprazole: A 6-Month, Real-Life Non-Interventional Study
BMC Psychiatry
Psychiatry
Mental Health
A Preliminary Cost Analysis of Schizophrenic Patients Stabilized on 1-Monthly Long Acting Paliperidone Palmitate (PP1M) Injection Switching to Paliperidone Palmitate 3-Monthly Formulation (PP3M) in the Public Sector of Hong Kong
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
